Peter A Merkel Selected Research

Wegener Granulomatosis (Wegener's Granulomatosis)

05/2008	Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
12/2007	The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
11/2007	Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
07/2007	ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
05/2007	Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
05/2006	Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
07/2005	Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

7	Wegener Granulomatosis (Wegener's Granulomatosis) 05/2008 - 07/2005
3	Systemic Scleroderma (Systemic Sclerosis) 06/2008 - 11/2006
3	Giant Cell Arteritis (Horton Disease) 08/2007 - 05/2002
1	Thrombophilia 12/2007
1	Skin Diseases 11/2006
1	Takayasu Arteritis (Arteritis, Takayasu's) 07/2004
1	Familial Mediterranean Fever (Periodic Disease) 08/2003
1	Muscular Diseases (Myopathy) 08/2003
1	Lung Diseases (Lung Disease) 04/2003

3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2007 - 04/2003
2	Methotrexate (Mexate)FDA LinkGeneric 08/2007 - 05/2002
2	TNFR-Fc fusion protein (etanercept)FDA Link 05/2006 - 07/2005
1	Collagen Type I (Type I Collagen)IBA 06/2008
1	GlucocorticoidsIBA 05/2008
1	Anticardiolipin AntibodiesIBA 12/2007
1	AntibodiesIBA 05/2007
1	infliximab (Remicade)FDA Link 05/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2007
1	CollagenIBA 11/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004
1	Colchicine FDA LinkGeneric 08/2003